# US 2010/0305055 A1 · Combinations of polyene fungicide with cationic surfactants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0305055 A1
- Document ID: US20100305055A1
- Status: Published application
- Kind: A1
- Application number: 12/675,823
- Filed: 2007-10-05
- Published: 2010-12-02
- Earliest claimed: 2007-09-13
- Assignees: Laboratorios Miret, S.A.
- Inventors: Xavier Rocabayera Bonvila; Sergi Figueras Roca; Roger Segret Pons; Eva Piera Eroles
- Web page: https://patentgrep.com/patent/US20100305055A1

## CPC

- A23B 4/22: Microorganisms; Enzymes; {Antibiotics}
- A01N 43/90: having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A23B 2/729: Organic compounds; Microorganisms; Enzymes
- A23B 2/7295: {Antibiotics}
- A23B 4/20: Organic compounds; Microorganisms; Enzymes
- A23B 11/67: of antibiotics
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A23B: PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A solid composition comprising a cationic surfactant, such as the ethyl ester of the lauramide of the arginine mono-hydrochloride (LAE) and a polyene fungicide such as natamycin is provided. The solid composition is the basis for providing solutions of natamycin of increased concentration. The solid composition may be used for providing a dispersion of natamycin in a suitable liquid, such as tap water or an organic solvent. The dispersion may be further diluted with water. This leads to a solution of natamycin in water. The combination of the cationic surfactant and the polyene fungicide displays a biological effect which is stronger than the effect of each of the two components alone.

## Claims

### Claim 1

A solid composition comprising at least one polyene fungicide and at least one cationic surfactant derived from the condensation of fatty acids and esterified dibasic amino acids, having the formula:
where:
X− is a counter ion derived from an organic or inorganic acid, the counter ion preferably being Br−, Cl−, or HSO4,
R1: is a straight alkyl chain from a saturated fatty acid or a hydroxy acid from 8 to 14 carbon atoms bonded to the α-amino acid group through amidic bond,
R2: is a straight or branched alkyl chain from 1 to 18 carbon atoms or an aromatic group,
R3: is:
where n can be from 0 to 4, and
optionally ingredients such as sugar, salt, anticakings, antioxidants, chelating agents, and thickening agents,
wherein the at least one cationic surfactant preservative derived from the condensation of fatty acids and esterified dibasic amino acid is the lauramide of the arginine monohydrochloride (LAE), and the polyene fungicide is natamycin,
the solid composition consisting of 2-99.9% by weight of LAE and 0.1-98% by weight of natamycin, the sum being 100%,
further containing excipients such as sugar, salt and anticaking in an amount of 0-5 parts by weight per 100 parts by weight of amount of LAE and natamycin.

### Claim 2 (depends on 1)

A method for preparing a dispersion of natamycin by the dispersion of the solid composition according to claim 1 in a solvent.

### Claim 3 (depends on 2)

The method of claim 2, in which the solvent is tap water or an organic solvent such as propylene glycol or glycerine, or a further food-grade solvent, or a combination of these solvents.

### Claim 4 (depends on 2)

A dispersion of a natamycin prepared by the method of claim 2, wherein the concentration of natamycin is between 100 ppm and 10,000 ppm, optionally comprising ingredients such as sugar, salt, anticakings, antioxidants, chelating agents, surfactants and thickening agents.

### Claim 5 (depends on 4)

A method for preparing an aqueous solution of natamycin by diluting the dispersion of claim 4 with water.

### Claim 6 (depends on 1)

A method for preparing an aqueous solution of natamycin by dissolving the solid composition of claim 1 in water.

### Claim 7 (depends on 5)

Aqueous solution obtainable by the method of claim 5, containing natamycin in a concentration of 10 to 10,000 ppm in combination with LAE in an amount of 200 to 100,000 ppm and optionally comprising ingredients such as sugar, salt, anticakings, antioxidants, chelating agents, surfactants and thickening agents.

### Claim 8 (depends on 7)

The aqueous solution according to claim 7, in which the ratio by weight of natamycin to LAE is 1:20 to 1:200.

### Claim 9 (depends on 7)

The aqueous solution according to claim 7, in which the preferred ratio by weight of natamycin to LAE is 1:50 to 1:100.

### Claim 10 (depends on 7)

The aqueous solution according to claim 7, wherein the concentration of natamycin is 0.001 to 0.15% (w/w).

### Claim 11 (depends on 10)

The aqueous solution according to claim 10, wherein the concentration of natamycin is 0.01 to 0.10% (w/w).

### Claim 12 (depends on 7)

A method of treating a food product, comprising using the aqueous solution of claim 7 to treat a product.

### Claim 13 (depends on 12)

The use method according to claim 12 wherein the aqueous solution is used to treat a cheese, cold meat products or bakery product.

### Claim 14 (depends on 12)

The method according to claim 12 wherein the aqueous solution is used to treat a liquid preparation.

### Claim 15 (depends on 1)

The method of treating a cosmetic preparation, comprising using the composition of claim 1 to treat a cosmetic preparation.

### Claim 16 (depends on 1)

The method of the preparing a medicament for treating infections in animals or human beings, comprising using the composition of claim 1 to prepare a medicament for treating infections in animals or human beings.
